RobertCharlesFrederichJr.MD

PubMed

• 43 citations
  Saxagliptin improves glycaemic control and C‐peptide secretion in latent autoimmune diabetes in adults (LADA)
  Raffaella Buzzetti, Paolo Pozzilli, Robert Frederich, Nayyar Iqbal, Boaz Hirshberg> ;Diabetes/metabolism Research and Reviews. 2016 Mar 1
• Heart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial.
  Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, Udell JA, Mosenzon O, Im K, Umez-Eronini AA, Pollack PS, Hirshberg B, Frederich R, Lewis BS, McGuire...> ;Circulation. 2015-10-13
• 30 citations
  Response to Letter Regarding Article, “Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial”
  Benjamin M. Scirica, Eugene Braunwald, Itamar Raz, Matthew A. Cavender, David A. Morrow, Petr Jarolim, Jacob A. Udell, Ofri Mosenzon, KyungAh Im, Amarachi A. Umez-Eron...> ;Circulation. 2015 Aug 11
• 66 citations
  Efficacy and Safety of Saxagliptin in Older Participants in the SAVOR-TIMI 53 Trial
  Lawrence A. Leiter, Hwee Teoh, Eugene Braunwald, Ofri Mosenzon, Avivit Cahn, K M Prasanna Kumar, Alena Smahelova, Boaz Hirshberg, Christina Stahre, Robert Frederich, F...> ;Diabetes Care. 2015 Jun 1
• 121 citations
  Saxagliptin and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Moderate or Severe Renal Impairment: Observations From the SAVOR-TIMI 53 Trial
  Jacob A. Udell, Deepak L. Bhatt, Eugene Braunwald, Matthew A. Cavender, Ofri Mosenzon, Ph. Gabriel Steg, Jaime A. Davidson, Jose C. Nicolau, Ramón Corbalán, Boaz Hirsh...> ;Diabetes Care. 2014 Dec 30
• Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial.
  Scirica BM, Braunwald E, Raz I, Cavender MA, Morrow DA, Jarolim P, Udell JA, Mosenzon O, Im K, Umez-Eronini AA, Pollack PS, Hirshberg B, Frederich R, Lewis BS, McGuire...> ;Circulation. 2014-10-28
• 50 citations
  Assessment of the cardiovascular safety of saxagliptin in patients with type 2 diabetes mellitus: pooled analysis of 20 clinical trials.
  Nayyar Iqbal, Artist Parker, Robert Frederich, Mark Donovan, Boaz Hirshberg> ;Cardiovascular Diabetology. 2014 Feb 4
• 2425 citations
  Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
  Benjamin M. Scirica, Deepak L. Bhatt, Eugene Braunwald, P. Gabriel Steg, Jaime A. Davidson, Boaz Hirshberg, Peter Öhman, Robert Frederich, Stephen D. Wiviott, Elaine B...> ;The New England Journal of Medicine. 2013 Oct 2
• 7 citations
  Saxagliptin Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease History or Cardiovascular Risk Factors: Results of a Pooled Analys...
  William Cook, Brian S Bryzinski, Jill Slater, Robert Frederich, Elsie Allen> ;Postgraduate Medicine. 2013 May 1
• 56 citations
  The efficacy and safety of the dipeptidyl peptidase-4 inhibitor saxagliptin in treatment-naïve patients with type 2 diabetes mellitus: a randomized controlled trial
  Robert Frederich, Robert McNeill, Niklas Berglind, Douglas Fleming, Roland Chen> ;Diabetology & Metabolic Syndrome. 2012 Jul 24
• 58 citations
  Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data
  Michael E. Cobble, Robert Frederich> ;Cardiovascular Diabetology. 2012 Jan 16
• 172 citations
  A Systematic Assessment of Cardiovascular Outcomes in the Saxagliptin Drug Development Program for Type 2 Diabetes
  Robert Frederich, John H. Alexander, Fred T. Fiedorek, Mark Donovan, Niklas Berglind, Susan Harris, Roland Chen, Robert Wolf, Kenneth W. Mahaffey> ;Postgraduate Medicine. 2010 May 1
• 46 citations
  Behavioral and subjective effects of D-amphetamine and modafinil in healthy adults.
  Angela P. Makris, Craig R. Rush, Robert Frederich, Alisia C. Taylor, Thomas H. Kelly> ;Experimental and Clinical Psychopharmacology. 2007 Apr 1
• 49 citations
  Wake-promoting agents with different mechanisms of action: comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity
  Angela P. Makris, Craig R. Rush, Robert Frederich, Thomas H. Kelly> ;Appetite. 2004 Apr 1
• 10 citations
  Anti-TNF-α Antibody Normalizes Serum Leptin in IL-2 Deficient Mice
  Lisa M Gaetke, Helieh S. Oz, Robert C Frederich, Craig J. McClain> ;Journal of the American College of Nutrition. 2003 Oct 1
• 31 citations
  Rosiglitazone amplifies the benefits of lifestyle intervention measures in long-standing type 2 diabetes mellitus.
  L. R. Reynolds, Elizabeth C. Konz, Robert C Frederich, James W. Anderson> ;Diabetes, Obesity & Metabolism. 2002 Jul 1
• 16 citations
  The Leptin Defense against Wasting Is Abolished in the IL-2–Deficient Mouse Model of Inflammatory Bowel Disease
  Lisa M. Gaetke, Helieh S. Oz, Willem J.S. de Villiers, Gary W. Varilek, Robert Frederich> ;The Journal of Nutrition. 2002 May 1
• 31 citations
  Decreased food intake rather than zinc deficiency is associated with changes in plasma leptin, metabolic rate, and activity levels in zinc deficient rats
  Lisa M. Gaetke, Robert C Frederich, Helieh S. Oz, Craig J. McClain> ;The Journal of Nutritional Biochemistry. 2002 Apr 1
• 16 citations
  Leptin in anorexia nervosa and bulimia nervosa: Importance of assay technique and method of interpretation
  Robert C Frederich, Shousheng Hu, Nancy C. Raymond, Claire Pomeroy> ;The Journal of Laboratory and Clinical Medicine. 2002 Feb 1
• 765 citations
  Long-term weight-loss maintenance: a meta-analysis of US studies
  James W. Anderson, Elizabeth C. Konz, Robert C Frederich, Constance L. Wood> ;The American Journal of Clinical Nutrition. 2001 Nov 1
• Join now to see all

Journal Articles

• Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes  
  Samuel Dagogo-Jack, Urszula Masiukiewicz, Robert Frederich, Darren K Mcguire, The New England Journal of Medicine